Commentary: Overall Survival in Heart Disease-Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study

Front Oncol. 2021 Apr 22:11:639042. doi: 10.3389/fonc.2021.639042. eCollection 2021.

Authors

Yiping Jiao¹, Chengqi Qian², Shumin Fei¹

Affiliations

¹ School of Automation, Southeast University, Nanjing, China.
² Jiangsu Chunyu Education Group Co., Ltd., Nanjing, China.

No abstract available

Keywords: adverse effects; heart diseases; immunotherapy; non-small cell lung cancer; survival analysis.

Publication types

Comment